News | July 13, 2011

TandemHeart Approved for Expanded Reimbursement

July 13, 2011 – The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC Corp., the medicare administrative contractor (MAC) serving over 1.3 million beneficiaries and over 53,000 healthcare providers in the Northeast region of the United States.

Physicians have utilized the TandemHeart device to provide critical heart support to over 2,500 patients at more than 170 of the top cardiac centers in the United States. The system is composed of a small centrifugal pump, a series of cannulae that connect the pump to the patient and an electro-mechanical controller. Starting from a small incision in a patient's leg, cannulae are inserted into the blood vessels and up to the heart. The TandemHeart pump is then activated, allowing damaged heart muscle to rest while augmenting the flow of blood to the patient's vital organs and the rest of the body.

NHIC's local coverage determination (LCD) for percutaneous ventricular assist devices (VAD) became effective July 8, 2011, and provides coverage of TandemHeart as a primary treatment option for a wide range of indications. It applies to Medicare beneficiaries throughout NHIC's jurisdiction, including those located in Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.

The U.S. Food and Drug Administration (FDA)-cleared TandemHeart system is the only heart assist device that can provide a high degree of circulatory support with a minimally invasive, percutaneous procedure. With flow rates up to five liters per minute, the TandemHeart delivers as much as five times the hemodynamic support as the standard of care intra-aortic balloon pump and twice the support of any other available percutaneous technology.

For more information: www.cardiacassist.com

Related Content

Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its...
Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018
At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully...
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Overlay Init